Viewing Study NCT01183494


Ignite Creation Date: 2025-12-25 @ 1:33 AM
Ignite Modification Date: 2025-12-25 @ 11:47 PM
Study NCT ID: NCT01183494
Status: COMPLETED
Last Update Posted: 2019-04-22
First Post: 2010-08-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Genotype-guided Study of Irinotecan Administered in Combination With 5-fluorouracil/Leucovorin (FOLFIRI) and Bevacizumab in Advanced Colorectal Cancer Patients
Sponsor: University of Chicago
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 09-277-B
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View